Copyright Reports & Markets. All rights reserved.

Global and United States Hereceptin Biosimilar Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Hereceptin Biosimilar Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Hereceptin Biosimilar Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Hereceptin Biosimilar Market Size Growth Rate by Type
    • 1.4.2 Tablet
    • 1.4.3 Capsule
  • 1.5 Market by Application
    • 1.5.1 Global Hereceptin Biosimilar Market Size Growth Rate by Application
    • 1.5.2 Pharmaceuticals
    • 1.5.3 Healthcare
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Hereceptin Biosimilar Market Size, Estimates and Forecasts
    • 2.1.1 Global Hereceptin Biosimilar Revenue 2015-2026
    • 2.1.2 Global Hereceptin Biosimilar Sales 2015-2026
  • 2.2 Global Hereceptin Biosimilar, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Hereceptin Biosimilar Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Hereceptin Biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Hereceptin Biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Hereceptin Biosimilar Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Hereceptin Biosimilar Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Hereceptin Biosimilar Revenue Forecast by Region (2021-2026)

3 Global Hereceptin Biosimilar Competitor Landscape by Players

  • 3.1 Global Top Hereceptin Biosimilar Sales by Manufacturers
    • 3.1.1 Global Hereceptin Biosimilar Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Hereceptin Biosimilar Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Hereceptin Biosimilar Manufacturers by Revenue
    • 3.2.1 Global Hereceptin Biosimilar Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Hereceptin Biosimilar Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Hereceptin Biosimilar Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Hereceptin Biosimilar Revenue in 2019
    • 3.2.5 Global Hereceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Hereceptin Biosimilar Price by Manufacturers
  • 3.4 Global Hereceptin Biosimilar Manufacturing Base Distribution, Product Types
    • 3.4.1 Hereceptin Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Hereceptin Biosimilar Product Type
    • 3.4.3 Date of International Manufacturers Enter into Hereceptin Biosimilar Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Hereceptin Biosimilar Market Size by Type (2015-2020)
    • 4.1.1 Global Hereceptin Biosimilar Sales by Type (2015-2020)
    • 4.1.2 Global Hereceptin Biosimilar Revenue by Type (2015-2020)
    • 4.1.3 Hereceptin Biosimilar Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Hereceptin Biosimilar Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Hereceptin Biosimilar Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Hereceptin Biosimilar Revenue Forecast by Type (2021-2026)
    • 4.2.3 Hereceptin Biosimilar Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Hereceptin Biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Hereceptin Biosimilar Market Size by Application (2015-2020)
    • 5.1.1 Global Hereceptin Biosimilar Sales by Application (2015-2020)
    • 5.1.2 Global Hereceptin Biosimilar Revenue by Application (2015-2020)
    • 5.1.3 Hereceptin Biosimilar Price by Application (2015-2020)
  • 5.2 Hereceptin Biosimilar Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Hereceptin Biosimilar Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Hereceptin Biosimilar Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Hereceptin Biosimilar Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application

  • 6.1 United States Hereceptin Biosimilar Market Size YoY Growth 2015-2026
    • 6.1.1 United States Hereceptin Biosimilar Sales YoY Growth 2015-2026
    • 6.1.2 United States Hereceptin Biosimilar Revenue YoY Growth 2015-2026
    • 6.1.3 United States Hereceptin Biosimilar Market Share in Global Market 2015-2026
  • 6.2 United States Hereceptin Biosimilar Market Size by Players (International and Local Players)
    • 6.2.1 United States Top Hereceptin Biosimilar Players by Sales (2015-2020)
    • 6.2.2 United States Top Hereceptin Biosimilar Players by Revenue (2015-2020)
  • 6.3 United States Hereceptin Biosimilar Historic Market Review by Type (2015-2020)
    • 6.3.1 United States Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
    • 6.3.2 United States Hereceptin Biosimilar Revenue Market Share by Type (2015-2020)
    • 6.3.3 United States Hereceptin Biosimilar Price by Type (2015-2020)
  • 6.4 United States Hereceptin Biosimilar Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 United States Hereceptin Biosimilar Sales Forecast by Type (2021-2026)
    • 6.4.2 United States Hereceptin Biosimilar Revenue Forecast by Type (2021-2026)
    • 6.4.3 United States Hereceptin Biosimilar Price Forecast by Type (2021-2026)
  • 6.5 United States Hereceptin Biosimilar Historic Market Review by Application (2015-2020)
    • 6.5.1 United States Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
    • 6.5.2 United States Hereceptin Biosimilar Revenue Market Share by Application (2015-2020)
    • 6.5.3 United States Hereceptin Biosimilar Price by Application (2015-2020)
  • 6.6 United States Hereceptin Biosimilar Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 United States Hereceptin Biosimilar Sales Forecast by Application (2021-2026)
    • 6.6.2 United States Hereceptin Biosimilar Revenue Forecast by Application (2021-2026)
    • 6.6.3 United States Hereceptin Biosimilar Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Hereceptin Biosimilar Market Size YoY Growth 2015-2026
  • 7.2 North America Hereceptin Biosimilar Market Facts & Figures by Country
    • 7.2.1 North America Hereceptin Biosimilar Sales by Country (2015-2020)
    • 7.2.2 North America Hereceptin Biosimilar Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Hereceptin Biosimilar Market Size YoY Growth 2015-2026
  • 8.2 Europe Hereceptin Biosimilar Market Facts & Figures by Country
    • 8.2.1 Europe Hereceptin Biosimilar Sales by Country
    • 8.2.2 Europe Hereceptin Biosimilar Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Hereceptin Biosimilar Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Hereceptin Biosimilar Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Hereceptin Biosimilar Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Hereceptin Biosimilar Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Hereceptin Biosimilar Market Size YoY Growth 2015-2026
  • 10.2 Latin America Hereceptin Biosimilar Market Facts & Figures by Country
    • 10.2.1 Latin America Hereceptin Biosimilar Sales by Country
    • 10.2.2 Latin America Hereceptin Biosimilar Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Hereceptin Biosimilar Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Hereceptin Biosimilar Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Hereceptin Biosimilar Sales by Country
    • 11.2.2 Middle East and Africa Hereceptin Biosimilar Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Mylan N.V.
    • 12.1.1 Mylan N.V. Corporation Information
    • 12.1.2 Mylan N.V. Description and Business Overview
    • 12.1.3 Mylan N.V. Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Mylan N.V. Hereceptin Biosimilar Products Offered
    • 12.1.5 Mylan N.V. Recent Development
  • 12.2 AryoGen Biopharma
    • 12.2.1 AryoGen Biopharma Corporation Information
    • 12.2.2 AryoGen Biopharma Description and Business Overview
    • 12.2.3 AryoGen Biopharma Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 AryoGen Biopharma Hereceptin Biosimilar Products Offered
    • 12.2.5 AryoGen Biopharma Recent Development
  • 12.3 Genor Biopharma
    • 12.3.1 Genor Biopharma Corporation Information
    • 12.3.2 Genor Biopharma Description and Business Overview
    • 12.3.3 Genor Biopharma Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Genor Biopharma Hereceptin Biosimilar Products Offered
    • 12.3.5 Genor Biopharma Recent Development
  • 12.4 Celltrion Inc.
    • 12.4.1 Celltrion Inc. Corporation Information
    • 12.4.2 Celltrion Inc. Description and Business Overview
    • 12.4.3 Celltrion Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Celltrion Inc. Hereceptin Biosimilar Products Offered
    • 12.4.5 Celltrion Inc. Recent Development
  • 12.5 Amgen Inc.
    • 12.5.1 Amgen Inc. Corporation Information
    • 12.5.2 Amgen Inc. Description and Business Overview
    • 12.5.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Amgen Inc. Hereceptin Biosimilar Products Offered
    • 12.5.5 Amgen Inc. Recent Development
  • 12.6 Mabion S.A.
    • 12.6.1 Mabion S.A. Corporation Information
    • 12.6.2 Mabion S.A. Description and Business Overview
    • 12.6.3 Mabion S.A. Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Mabion S.A. Hereceptin Biosimilar Products Offered
    • 12.6.5 Mabion S.A. Recent Development
  • 12.7 The Instituto Vital Brazil
    • 12.7.1 The Instituto Vital Brazil Corporation Information
    • 12.7.2 The Instituto Vital Brazil Description and Business Overview
    • 12.7.3 The Instituto Vital Brazil Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 The Instituto Vital Brazil Hereceptin Biosimilar Products Offered
    • 12.7.5 The Instituto Vital Brazil Recent Development
  • 12.8 F. Hoffmann-La Roche AG
    • 12.8.1 F. Hoffmann-La Roche AG Corporation Information
    • 12.8.2 F. Hoffmann-La Roche AG Description and Business Overview
    • 12.8.3 F. Hoffmann-La Roche AG Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 F. Hoffmann-La Roche AG Hereceptin Biosimilar Products Offered
    • 12.8.5 F. Hoffmann-La Roche AG Recent Development
  • 12.9 Biocon
    • 12.9.1 Biocon Corporation Information
    • 12.9.2 Biocon Description and Business Overview
    • 12.9.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Biocon Hereceptin Biosimilar Products Offered
    • 12.9.5 Biocon Recent Development
  • 12.10 Gedeon Richter Plc
    • 12.10.1 Gedeon Richter Plc Corporation Information
    • 12.10.2 Gedeon Richter Plc Description and Business Overview
    • 12.10.3 Gedeon Richter Plc Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 Gedeon Richter Plc Hereceptin Biosimilar Products Offered
    • 12.10.5 Gedeon Richter Plc Recent Development
  • 12.11 Mylan N.V.
    • 12.11.1 Mylan N.V. Corporation Information
    • 12.11.2 Mylan N.V. Description and Business Overview
    • 12.11.3 Mylan N.V. Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Mylan N.V. Hereceptin Biosimilar Products Offered
    • 12.11.5 Mylan N.V. Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Hereceptin Biosimilar Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Hereceptin Biosimilar Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Hereceptin Biosimilar market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hereceptin Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Hereceptin Biosimilar market is segmented into
    Tablet
    Capsule

    Segment by Application, the Hereceptin Biosimilar market is segmented into
    Pharmaceuticals
    Healthcare
    Others

    Regional and Country-level Analysis
    The Hereceptin Biosimilar market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Hereceptin Biosimilar market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Hereceptin Biosimilar Market Share Analysis
    Hereceptin Biosimilar market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hereceptin Biosimilar business, the date to enter into the Hereceptin Biosimilar market, Hereceptin Biosimilar product introduction, recent developments, etc.
    The major vendors covered:
    Mylan N.V.
    AryoGen Biopharma
    Genor Biopharma
    Celltrion Inc.
    Amgen Inc.
    Mabion S.A.
    The Instituto Vital Brazil
    F. Hoffmann-La Roche AG
    Biocon
    Gedeon Richter Plc

    Buy now